For decades, taking a daily low-dose aspirin was a widely accepted practice for preventing heart attacks and strokes. But a series of clinical trials have led to a major shift in medical guidance — ...

A new study published in the Nature Scientific Reports highlighted the potential benefits of aspirin in reducing biochemical recurrence (BCR) rates following robot-assisted radical ...

The global aspirin drug market is poised for substantial growth over the next decade, with its value expected to increase ...